ReviewTherapeutic advances in medical oncology2025

Controversies and clinical unknowns in the use of PARP inhibitors in ovarian cancer.

Uma A Mukherjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.